CIK 0001820190
- Emerging growth company
Scilex Holding Co
Sign in to watch- Ticker
- SCLX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-516-4310
- Business address
- 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
- Former names
- Scilex Holding Company/DE, Vickers Vantage Corp. I
Securities
- SCLX Common Stock Nasdaq
- SCLXW Warrant Nasdaq
- 4 Option exercise Chief Financial Officer acquired 2,000 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- 4 Option exercise See Remarks acquired 14,000 shares (option exercise)
- 4 Option exercise Executive Chairperson acquired 6,000 shares (option exercise)
- 4 Option exercise See Remarks acquired 33,333 shares (option exercise)
- 4 Open-market buy Executive Chairperson bought 50,000 shares at $0.88 ($43,985)
- 4 Open-market buy Director bought 57,500 shares at $0.90 ($51,641)
- 4 Open-market buy See Remarks bought 140,000 shares at an average $0.87 ($121,945)
- 4 Open-market buy Chief Financial Officer bought 14,140 shares at $0.88 ($12,443)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 5 · 93 filings